Project Grant R01DE036187
Award Date 9/1/26
Completion Date 5/31/31
Dollars Obligated $606K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60610, USA
Similar Awards
- The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health under the Department of Health and Human Services, awarded The University of Chicago $328,000 on August 5, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate a microsimulation model of oral health lifetime outcomes and resource use in older adults. The project, titled "Development and Validation of the U.S. Oral Health Microsimulation...
- The National Institute of Dental and Craniofacial Research awarded The University of Chicago $133,239 on April 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and deliver a research education program called Cultivating Researchers in Oral and Systemic Health Studies (CROSS). The program trains undergraduate students enrolled in colleges across the Chicago area in cross-disciplinary clinical research that integrates oral health, medicine, and the social...
- The National Institute of Dental and Craniofacial Research, part of the National Institutes of Health within the Department of Health and Human Services, awarded $435,875 to Indiana University Indianapolis on July 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate oxylipin-mediated biofilm colonization in peri-implant disease. The research explores the role of oxylipins in regulating bacterial biofilm formation around dental implants. The study aims...
- The National Institute of Dental and Craniofacial Research awarded Health Research, Inc. (Roswell Park Division) $347,000 on July 8, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct a large-scale population-based study examining how the use of reduced-exposure nicotine products—electronic nicotine products and oral nicotine pouches—impacts oral health conditions among adults who formerly used combustible or smokeless tobacco in the United States. The research...
- The National Institute of Dental and Craniofacial Research awarded the University of Alabama at Birmingham $666,812 under the Oral Diseases and Disorders Research program (CFDA 93.121) on July 14, 2026, for a multilevel retrospective cohort study examining the impacts of Medicaid dental benefits expansion on oral healthcare workforce composition and services delivery at federally qualified health centers. The research employs an event-study difference-in-differences design using Uniform Data...
- The National Institute of Dental and Craniofacial Research awarded Oregon Health & Science University $557,951 on August 26, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate an experimental polymicrobial abscess model system for investigating the role of microbial synergy in oral inflammatory dysbiosis. The research platform uses patient-matched human dental plaque and odontogenic abscess specimens introduced into mice to recapitulate the...
- The National Institute of Dental and Craniofacial Research, an operating division of the Department of Health and Human Services National Institutes of Health, awarded Regents of the University of Michigan $600,214 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to define the neuronal basis of odontogenic pain and identify targets for non-opioid analgesic development. The project, led by Dr. Joshua Emrick, investigates the cells, circuits, and behavioral...
- The National Institute of Dental and Craniofacial Research awarded the University of Texas Medical Branch at Galveston $323,000 on July 9, 2026, to model causal mediation by dental care and predict jaw osteonecrosis risk in bisphosphonate users under the Oral Diseases and Disorders Research program (CFDA 93.121). The research addresses a critical clinical gap in managing osteonecrosis of the jaw (ONJ)—a debilitating adverse event marked by exposed necrotic bone, persistent infection, and...
- The National Institute of Dental and Craniofacial Research awarded the University of Arizona $371,900 on August 3, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop innovative methods for evidence synthesis in oral health research. The project addresses barriers in current oral health evidence synthesis by developing oral-health-specific artificial intelligence tools, methodological resources, and analytical approaches. Aim 1 validates and adapts AI tools...
- The National Institute of Dental and Craniofacial Research, within the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $320,660 on July 9, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop anionic nanohybrid aggregate formulations for early childhood caries prevention. The project addresses early childhood caries affecting approximately 25 percent of American preschool children, particularly those of...